NanoString | Life science tools for translational research and molecular diagnostics

GeoMx™ Digital Spatial Profiler

Map the Microenvironment
Learn more
PanCancer IO 360 Panel

Explore the NEW
Data Analysis Report
Learn more
GeoMx™ Digital Spatial Profiler

Your GPS for Biology
Learn more
New!

nCounter®
Fibrosis Panel
Learn More
Prosigna® Breast Cancer Prognostic Gene Signature Assay

It's Time
to Move Forward
Learn More
Faster than qPCR. Simpler than NGS.

nCounter®
SPRINT
Profiler
Learn more

nCounter® Analysis Technology

More insights from
less sample

Download nSolver™ 4.0 and
Advanced Analysis 2.0 updates!
Learn More

Stay nFormed

The nForm blog provides expert opinions on the latest hot topics in research from Neuroscience to spatial profiling and beyond!

View Blog

Hear from the Experts

Register for one of our on-demand webinars to hear how customers are using nCounter Technology and also learn about new products in development.
Watch Now

FOCUSED

on actionable answers

Immuno-
Oncology

Cancer
Research

Neuroscience
Research

Immunology &
Inflammation

Infectious
Disease

nFORM BLOG - Digital Spatial Profiling

Spatial Profiling using the GeoMx RNA Assay for NGS Readout: Robust Technology for Identification of Novel Biomarkers and Early Detection of Melanoma

Check out the highlights from our recent webinar where Dr. Maragaret Hoang discusses how users can achieve reliable, reproducible analyses of FFPE tissue samples using the GeoMx DSP technology and Dr. Kiuru presenting data from her team's study "Identification of cell type-specific RNA biomarker candidtes in melanocytic tumors using digital spatial profiling."

November 19, 2019

A Transcriptomic Solution Customized for Your Every Need

Learn about our applications for Animal & Agriculture Research in our new blog! The flexibility of the NanoString® nCounter® platform has been designed to accommodate a wide range of organisms, molecular targets, and sample inputs. Researchers can request “made-to-order” Custom CodeSets for up to 800 project-specific mRNA targets. In doing so, they can take advantage of the sensitivity of direct, digital detection for their genes of interest at a fraction of the time and cost it takes to sequence a whole transcriptome.

November 11, 2019